BRVE Earnings Results and History
Braveheart Bio, Inc.'s earnings at a glance: the latest results and outlook from the press release, revenue, margins and EPS for every quarter from the company's SEC filings, and how the stock moved after each report. New results show here within about a minute of being filed.
- EPS−$0.51
- Revenue–
Filed ยท Press release
Filings and dates
SEC EDGAR- Feb 9, 2027Next earnings reportexpected
- Nov 10, 2026Earnings release, Q3 20268-K Press release
Also see BRVE institutional ownership and the earnings calendar.
BRVE earnings FAQ
What were BRVE's latest earnings?
For Q3 2026 Braveheart Bio, Inc. reported, GAAP EPS of -$0.51. The results were filed with the SEC on Nov 10, 2026.
When is BRVE's next earnings date?
Braveheart Bio, Inc. is expected to report on Feb 9, 2027. Dates can move until the company confirms them.
Where do these numbers come from?
Results, guidance and financials come from Braveheart Bio, Inc.'s own SEC filings: the earnings press release (Form 8-K) and the quarterly and annual reports (10-Q and 10-K). Key takeaways summarize the press release. Estimates and price moves come from market data.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Results come from company filings with the SEC. Estimates are consensus figures from before each report. Key takeaways summarize the company's press release and may contain errors; the press release is the authoritative source.